Lingohr Asset Management GmbH bought a new position in Amrize Ltd (NYSE:AMRZ – Free Report) during the third quarter, according to its most recent 13F filing with the SEC. The institutional investor bought 71,930 shares of the company’s stock, valued at approximately $3,475,000.
Other hedge funds and other institutional investors have also recently modified their holdings of the company. Vanguard Group Inc. purchased a new stake in Amrize during the second quarter valued at approximately $1,065,029,000. Norges Bank acquired a new stake in Amrize during the second quarter worth about $670,915,000. Dodge & Cox acquired a new stake in Amrize during the second quarter valued at $622,085,000. JPMorgan Chase & Co. acquired a new stake in Amrize in the second quarter valued at approximately $220,404,000. Finally, Legal & General Group Plc acquired a new stake in shares of Amrize in the second quarter valued at about $161,761,000.
Amrize Trading Down 2.8%
Shares of Amrize stock opened at $52.64 on Friday. The company has a debt-to-equity ratio of 0.38, a quick ratio of 0.97 and a current ratio of 1.45. Amrize Ltd has a 12-month low of $44.12 and a 12-month high of $58.11. The firm has a market cap of $29.11 billion and a PE ratio of 28.61. The firm has a fifty day moving average of $54.24.
Insiders Place Their Bets
In other Amrize news, insider Jaime Hill acquired 4,000 shares of the company’s stock in a transaction on Tuesday, November 4th. The shares were bought at an average cost of $50.69 per share, for a total transaction of $202,760.00. Following the completion of the purchase, the insider owned 18,101 shares in the company, valued at $917,539.69. This trade represents a 28.37% increase in their position. The purchase was disclosed in a filing with the SEC, which is accessible through this hyperlink. Also, Director Nicholas C. Gangestad acquired 2,000 shares of Amrize stock in a transaction on Wednesday, November 19th. The shares were bought at an average cost of $47.34 per share, with a total value of $94,680.00. Following the completion of the purchase, the director owned 4,958 shares in the company, valued at $234,711.72. The trade was a 67.61% increase in their ownership of the stock. Additional details regarding this purchase are available in the official SEC disclosure.
Analyst Ratings Changes
AMRZ has been the topic of several research reports. Kepler Capital Markets raised shares of Amrize to a “strong-buy” rating in a research note on Tuesday, October 21st. Wall Street Zen raised Amrize to a “hold” rating in a research report on Saturday, October 25th. Sanford C. Bernstein reiterated an “outperform” rating and issued a $70.00 target price on shares of Amrize in a report on Thursday, December 18th. Deutsche Bank Aktiengesellschaft set a $59.00 target price on Amrize in a research report on Monday, December 8th. Finally, Weiss Ratings downgraded shares of Amrize from a “buy (b-)” rating to a “hold (c+)” rating in a research note on Tuesday. One analyst has rated the stock with a Strong Buy rating, seven have given a Buy rating and seven have issued a Hold rating to the stock. According to data from MarketBeat, Amrize has an average rating of “Moderate Buy” and an average target price of $60.75.
Get Our Latest Analysis on AMRZ
Amrize Company Profile
Amrize AG focuses on building materials business in North America. The company was incorporated in 2023 and is based in Zug, Switzerland. Amrize AG operates independently of Holcim AG as of June 23, 2025.
Further Reading
- Five stocks we like better than Amrize
- Do not delete, read immediately
- NEW LAW: Congress Approves Setup For Digital Dollar?
- “Fed Proof” Your Bank Account with THESE 4 Simple Steps
- A U.S. “birthright” claim worth trillions – activated quietly
- The Crash Has Already Started (Most Just Don’t See It Yet)
Want to see what other hedge funds are holding AMRZ? Visit HoldingsChannel.com to get the latest 13F filings and insider trades for Amrize Ltd (NYSE:AMRZ – Free Report).
Receive News & Ratings for Amrize Daily - Enter your email address below to receive a concise daily summary of the latest news and analysts' ratings for Amrize and related companies with MarketBeat.com's FREE daily email newsletter.
